167 related articles for article (PubMed ID: 36974558)
1. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer.
Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
Hu J; Hu B; Gui YC; Tan ZB; Xu JW
Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
[TBL] [Abstract][Full Text] [Related]
3. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
[TBL] [Abstract][Full Text] [Related]
5. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract][Full Text] [Related]
6. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor.
Leerhoff S; Raem A; Kolbe EW; Schulz L; Borchers K; Köhler T; Winde G; Kirchner C
Cancer Treat Res Commun; 2023; 36():100748. PubMed ID: 37541105
[TBL] [Abstract][Full Text] [Related]
7. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.
Song L; Wang J; Wang H; Chen Y; Jia J; Guo S; Liu H; Peng X; Xiao W; Gong Y; Yang B; Lu Y; Li Y
Epigenomics; 2018 Dec; 10(12):1569-1583. PubMed ID: 30426784
[TBL] [Abstract][Full Text] [Related]
8. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
[TBL] [Abstract][Full Text] [Related]
9. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
10. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
[TBL] [Abstract][Full Text] [Related]
11. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
[TBL] [Abstract][Full Text] [Related]
12. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
13. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
[TBL] [Abstract][Full Text] [Related]
14. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
[TBL] [Abstract][Full Text] [Related]
15. Methylated Septin9 (m
Loomans-Kropp HA; Song Y; Gala M; Parikh AR; Van Seventer EE; Alvarez R; Hitchins MP; Shoemaker RH; Umar A
Cancer Res Commun; 2022 Feb; 2(2):90-98. PubMed ID: 35992328
[TBL] [Abstract][Full Text] [Related]
16. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
[TBL] [Abstract][Full Text] [Related]
17. The stool
Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
[TBL] [Abstract][Full Text] [Related]
18. The value of serum methylated septin 9 and carcinoembryonic antigen in efficacy evaluation and follow-up monitoring of colorectal cancer.
Gao H; Zhu ZQ; Wusiman L; Wujieke A; Zhang WB
Ann Ital Chir; 2023; 94():384-391. PubMed ID: 37794798
[TBL] [Abstract][Full Text] [Related]
19. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
20. Methylated
Hitchins MP; Vogelaar IP; Brennan K; Haraldsdottir S; Zhou N; Martin B; Alvarez R; Yuan X; Kim S; Guindi M; Hendifar AE; Kalady MF; DeVecchio J; Church JM; de la Chapelle A; Hampel H; Pearlman R; Christensen M; Snyder C; Lanspa SJ; Haile RW; Lynch HT
BMJ Open Gastroenterol; 2019; 6(1):e000299. PubMed ID: 31275589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
